Amneal Announces the Launch of Generic Esomeprazole Strontium Delayed-Release Capsules 49.3 mg / by TI

Amneal Pharmaceuticals LLC today announced the launch of generic Esomeprazole strontium delayed-release capsules 49.3 mg. This new esomeprazole therapy is the generic equivalent of the recently launched brand Esomeprazole strontium. It contains the same active moiety (esomeprazole) in a different salt form as found in the leading PPI brand Nexium® (esomeprazole magnesium) and presents a potentially more affordable treatment option for GERD in adult patients.

Available in a 49.3 mg strength, each esomeprazole strontium capsule provides the equivalent of 40 mg of esomeprazole1 – the same amount of esomeprazole that is present in the 40 mg Nexium® capsule. Esomeprazole strontium capsules will be sold in 30-count bottles and are the authorized generic equivalent for their branded counterpart by the same name (Esomeprazole strontium delayed-release capsules 49.3 mg), which Amneal launched in December 2013.